Irinotecan Kabi 20 mg/ml concentrate for solution for infusion

Pays: Bulgarie

Langue: bulgare

Source: Изпълнителна агенция по лекарствата

Ingrédients actifs:

Иринотекан

Disponible depuis:

Fresenius Kabi Oncology Plc.

Code ATC:

L01XX19

DCI (Dénomination commune internationale):

Irinotecan

Dosage:

20 mg/ml concentrate for solution for infusion

Descriptif du produit:

Irinotecan Kabi, 20 mg/ml concentrate for solution for infusion - 2 ml x 1;2 ml x 5; 5 ml x 1; 5 ml x 5

Date de l'autorisation:

2013-12-18